Dr. Kwiatkowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Shattuck St.
Boston, MA 02115Phone+1 857-307-0781Fax+1 617-394-2769
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology
Certifications & Licensure
MA State Medical License 1986 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
- Super Doctor SuperDoctors.com
Clinical Trials
- Everolimus for Cancer With TSC1 or TSC2 Mutation Start of enrollment: 2014 Sep 01
- Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations Start of enrollment: 2017 Aug 24
Publications & Presentations
PubMed
- Vigabatrin-associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex.Carmen Stevering, Maarten Lequin, Kinga Szczepaniak, Krzysztof Sadowski, Saba Ishrat
Epilepsia. 2025-02-01 - 1 citationsDeep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer.Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao V Alessi, Alessio Cortellini
JAMA Oncology. 2025-02-01 - Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.Ritujith Jayakrishnan, David J Kwiatkowski, Michal G Rose, Amin H Nassar
The Oncologist. 2024-10-03
Journal Articles
- Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive CellsDarcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018
Press Mentions
Study Identifies Genomic Predictors of Outcomes in High-Risk Bladder CancerSeptember 23rd, 2020
Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019
Grant Support
- Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
- Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
- Molecular Pathogenesis of the Hamartoma SyndromesBRIGHAM AND WOMEN'S HOSPITAL2007–2028
- Genetics of LAMBRIGHAM AND WOMEN'S HOSPITAL2020–2025
- Mouse Brain Models Of Tuberous SclerosisNational Institute Of Neurological Disorders And Stroke2008–2012
- Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2007–2012
- The Lymphangioleiomyomatosis (Lam)Genome AtlasNational Heart, Lung, And Blood Institute2009–2010
- Preclinical Studies Of Rapamycin For TSC Brain DiseaseNational Institute Of Neurological Disorders And Stroke2004–2006
- Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2002–2006
- Genotyping Center For Innate Immunity PGANational Heart, Lung, And Blood Institute2000–2004
- Gelsolin: Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2001–2003
- Murine Models Of Tsc1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001–2002
- Murine Models Of TSC 1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001
- Tuberous Sclerosis--Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke1998–2001
- Gelsolin--Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2000
- Actin Regulatory Proteins In Arterial DysfunctionNational Heart, Lung, And Blood Institute1997–1998
- Gelsolin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1996–1998
- Tuberous Sclerosis Gene On 9q34National Institute Of Neurological Disorders And Stroke1994–1997
- Gelsonlin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1995
- International Workshop On Human Chromosome 9National Human Genome Research Institute1994
- Human Chromosome 9National Human Genome Research Institute1993
- MAP Of Human Chromosome 9National Human Genome Research Institute1991–1993
- Molecular Biology Of GelsolinNational Heart, Lung, And Blood Institute1985–1989
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
